secwatch.observer — SEC 8-K summary
======================================

Issuer:     Rani Therapeutics Holdings, Inc. (RANI)
CIK:        0001856725
Form:       8-K
Filed at:   2026-05-28T22:12:37+00:00
Accession:  0001193125-26-245636
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Rani Therapeutics shareholders elect all 7 directors, ratify auditor at 2026 annual meeting
--------------------------------------------------------------------------------

- All director nominees elected with >57M votes each; Jean-Luc Butel had highest withhold (4,997,042).
- Ratification of CBIZ CPAs as auditor for FY2026 passed with 77,019,828 for, 332,645 against, 54,190 abstain.
- Record date had 99,812,515 Class A and 23,970,359 Class B shares outstanding, voting together as a single class.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1856725/000119312526245636/0001193125-26-245636-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1856725/000119312526245636/rani-20260528.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-245636

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer